User profiles for K. MICHAUD

Kaleb Michaud, PhD

Professor, University of Nebraska Medical Center; Co-Director, FORWARD
Verified email at unmc.edu
Cited by 26190

[PDF][PDF] Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice

…, ML Robbins, T Neogi, K Michaud… - Arthritis care & …, 2012 - Wiley Online Library
Michaud has received consultant fees, speaking fees, and/or honoraria (less than $10,000)
from the Mayo Foundation. Dr. Saag has received consultant fees, speaking fees, and/or …

[HTML][HTML] Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases

SE Gabriel, K Michaud - Arthritis research & therapy, 2009 - Springer
Epidemiology is the study of the distribution and determinants of disease in human populations.
Over the past decade there has been considerable progress in our understanding of the …

Comorbidities in rheumatoid arthritis

K Michaud, F Wolfe - Best practice & research Clinical rheumatology, 2007 - Elsevier
… Summary relationship between number of comorbidities and quality of life (QOL) using
EuroQol-5D (EQ-5D) and the Michaud/Wolfe comorbidity index from a random observation in …

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

…, R Landewé, J Listing, K Michaud… - Arthritis & …, 2011 - Wiley Online Library
Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti–tumor necrosis factor therapy in 18,572 patients

F Wolfe, K Michaud - Arthritis & Rheumatism: Official Journal of …, 2004 - Wiley Online Library
Objective The risk of lymphoma is increased in patients with rheumatoid arthritis (RA), and
spontaneous reporting suggests that methotrexate (MTX) and anti–tumor necrosis factor (anti‐…

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

…, M Matucci‐Cerinic, K Michaud… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To make recommendations on how to report disease activity in clinical trials of
rheumatoid arthritis (RA) endorsed by the European League Against Rheumatism (EULAR) and …

Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study

F Wolfe, K Michaud - Arthritis & Rheumatism: Official Journal of …, 2007 - Wiley Online Library
Objective Induction of malignancy is a major concern when rheumatoid arthritis (RA) is
treated with biologic therapy. A meta‐analysis of RA biologic clinical trials found a general …

Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy

…, K Michaud, J Anderson, K Urbansky - Arthritis & Rheumatism …, 2004 - Wiley Online Library
Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000
incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per …

Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease‐modifying antirheumatic drugs, and anti–tumor …

F Wolfe, L Caplan, K Michaud - Arthritis & Rheumatism: Official …, 2006 - Wiley Online Library
Objective Pneumonia is a major cause of mortality and morbidity in rheumatoid arthritis (RA).
This study was undertaken to determine the rate and predictors of hospitalization for …

Predicting mortality in patients with rheumatoid arthritis

F Wolfe, K Michaud, O Gefeller… - Arthritis & Rheumatism …, 2003 - Wiley Online Library
Objective A number of different variables have been proposed as risk factors for mortality in
patients with rheumatoid arthritis (RA), but limited prospective information on the magnitude …